| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/23/2006 | US20060039959 Film-Shaped Mucoadhesive Administration Forms For Administering Cannabis Agents |
| 02/23/2006 | US20060039947 Biologically active implants |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039903 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | CA2577448A1 Androgen modulators |
| 02/23/2006 | CA2577274A1 Anti-inflammatory agents |
| 02/23/2006 | CA2575787A1 Dihydropteridinones for the treatment of cancer diseases |
| 02/23/2006 | CA2573761A1 Use of estrogen related receptor-modulating aryl ethers |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1627870A1 Cyanofluoropyrrolidine derivative |
| 02/22/2006 | EP1627636A1 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 02/22/2006 | EP1626736A1 C1 inhibitor with short half-life for transient treatment |
| 02/22/2006 | EP1626725A2 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 02/22/2006 | EP1414812B1 Hydroxamic acid derivatives |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1296706B1 Osteoclast secreted chemokine and uses thereof |
| 02/22/2006 | EP1251857B1 Pharmaceutical parenteral composition containing a bisphosphonate |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | EP1212464B1 Diagnostics and therapeutics for osteoporosis |
| 02/22/2006 | EP0957929B1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/22/2006 | CN1738817A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same. |
| 02/22/2006 | CN1738806A Oxo-azabicyclic compounds |
| 02/22/2006 | CN1738788A Substituted phenyl naphthalenes as estrogenic agents |
| 02/22/2006 | CN1738625A Benzo (1,2,5) thiadiazole ALS CRF-antagonisten |
| 02/22/2006 | CN1738624A Method of treatment of myocardial infarction |
| 02/22/2006 | CN1737009A Polypeptide compound and its medicinal uses |
| 02/22/2006 | CN1736981A Selective androgen receptor modulators and methods of use thereof |
| 02/22/2006 | CN1736466A Use of straw extract |
| 02/22/2006 | CN1736451A Externally applied plaster for stopping muscles and bones pain |
| 02/22/2006 | CN1736448A Medicinal preparation for treating cold abscess and all kinds of body surface ulcer |
| 02/22/2006 | CN1736427A Ointment for treating traumatic injury and its preparation method |
| 02/22/2006 | CN1736421A Main ingredient of anemone rhizome, preparation process and application thereof |
| 02/22/2006 | CN1736419A Prescription of wine for treating arthritis and bony spur and manufacturing method thereof |
| 02/22/2006 | CN1736410A Film coated tablet for bone injury and preparation process thereof |
| 02/22/2006 | CN1736409A Pills for treating hyperosteogeny of cervical vertebra and lumbar vertebra |
| 02/22/2006 | CN1736408A Chinese herbal medicinal preparation for treating hyperosteogeny |
| 02/22/2006 | CN1736407A Wind arthralgia treating wine and manufacturing method thereof |
| 02/22/2006 | CN1736405A Medicinal liquor for treating rheumatism |
| 02/22/2006 | CN1736401A Preparation for bone injury and preparation process |
| 02/22/2006 | CN1736389A Application of sodium selenite in preparation of medicine for treating wind, dampness and cold caused arthralgia |
| 02/22/2006 | CN1736371A Selective androgen receptor modulators and methods of use thereof |
| 02/22/2006 | CN1736368A Paeonol soft capsule, its preparing process and application |
| 02/22/2006 | CN1243018C Blood vessel generating inhibitor |
| 02/22/2006 | CN1243000C Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof |
| 02/22/2006 | CN1242813C Combination therapy for osteoporosis |
| 02/22/2006 | CN1242804C External used medicine for traumatic injury and preparation thereof |
| 02/22/2006 | CN1242777C Muscle and bone pain plaster and its making method |
| 02/22/2006 | CN1242774C Medicine for treating proliferation arthritis of spine and its preparation method |
| 02/22/2006 | CN1242764C Traditional Chinese medicine for treating spondylitis |
| 02/22/2006 | CN1242759C Chinese medicine injection for bone fracture heeling |
| 02/22/2006 | CN1242756C Chinese medicine for trauma and preparation method |
| 02/21/2006 | US7001917 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents |
| 02/21/2006 | US7001914 Compounds |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/21/2006 | US7001899 7-member ring N-heterocycles that have a cysteine trap substitution; treating osteoarthritis |
| 02/21/2006 | US7001617 Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| 02/21/2006 | US7001595 For therapy of rheumatoid arthritis, inflammation, respiratory diseases, allergy |
| 02/21/2006 | CA2395196C Cyclic amp-specific phosphodiesterase inhibitors |
| 02/21/2006 | CA2110443C Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use |
| 02/16/2006 | WO2006017406A1 Cyanoamidine p2x7 antagonists for the treatment of pain |
| 02/16/2006 | WO2003033720A8 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060035979 Inhibitors of transcription factor NF-kappaB |
| 02/16/2006 | US20060035948 e.g. 6-nitro-4-[N-(4-chlorophenyl)-N-(2-methyl-2H-tetrazol-5-ylmethyl)amino]-3-hydroxy-2-methyl-2-dimethoxymethyl-3,4-dihydro-2H-1-benzopyran; protecting neuronal cells from oxidative stress induced cell death by iron or by hydrogen peroxide; antihypoxic agent, neuroprotectant |
| 02/16/2006 | US20060035925 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/16/2006 | US20060035876 Combination therapy of an SODm and a corticosteroid for prevention and/or treatment of inflammatory bone or joint disease |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035847 e.g. 1,2-Dihydro-4-[(4-isopropoxyphenyl)methyl]-5-methyl-3H-pyrazol-3-one; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; synergistic mixture with other active compounds |
| 02/16/2006 | US20060035840 Beta-D-Glucopyranosyloxy)-3-(3-fluoro-4-methylbenzyl)-4,6-dimethylpyridine; sodium glucose co-transporter 2 (SGLT2) inhibitors; excellent hypoglycemic effect by excreting excess glucose into the urine through preventing the reabsorption of glucose at the kidney; antidiabetic agents; hyperglycemia |
| 02/16/2006 | US20060035374 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
| 02/16/2006 | US20060035268 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 02/16/2006 | US20060034893 Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation |
| 02/16/2006 | US20060034864 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 02/16/2006 | CA2576949A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 02/15/2006 | EP1626049A1 Microcrystal |
| 02/15/2006 | EP1626048A1 Crystal of benzimidazole derivative and process for producing the same |
| 02/15/2006 | EP1625847A1 Pharmaceutical composition comprising a tetrahydrotriazolo[4,3-a]pyrazine |
| 02/15/2006 | EP1625166A1 Antibodies to masp-2 |
| 02/15/2006 | EP1625127A1 Azaindole compounds as kinase inhibitors |
| 02/15/2006 | EP1625126A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 02/15/2006 | EP1624878A1 Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain |
| 02/15/2006 | EP1624856A2 Method of preparing a formulation containing a microdosed active principle |
| 02/15/2006 | EP1482872A4 Tissue repair matrix |
| 02/15/2006 | EP1482787A4 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 02/15/2006 | EP1341533B1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 02/15/2006 | CN1735630A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 02/15/2006 | CN1735629A Single domain antibodies directed against tumor necrosis factor alpha and uses therefor |
| 02/15/2006 | CN1735615A Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1733877A Conjugated linolic acid containing high content t10 and c12 |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733297A Joint nutrient tablet |
| 02/15/2006 | CN1733285A Film-coated tablet for increasing bone force and process for preparing the same |
| 02/15/2006 | CN1733284A Medicine for treating gout |
| 02/15/2006 | CN1733269A Drop pill made from root rhizome and herb of common lamiophlomis and process for preparing the same |
| 02/15/2006 | CN1733268A Heat clearing and detoxicating pill containing vomiting nut |